Early Monitoring Antiangiogenesis Treatment Response of Sunitinib in U87MG Tumor Xenograft by ¹⁸F-FLT MicroPET/CT Imaging

Figure 3

Quantitative ROIs analysis of tumor uptake from ¹⁸F-FLT microPET/CT. ((a) SUV_max, (b) SUV_mean, (c) %ID/g_max, and (d) %ID/g_mean) *𝑃<0.05 and ^∗∗𝑃<0.01, within the Sunitinib group, compared to day 0. ^■𝑃<0.05, between the Sunitinib group and the control group.

(a)

(b)

(c)

(d)